A study of hyperhomocysteinemia in cerebral venous sinus thrombosis

Jayantee Kalita1, Varun K Singh1, Usha Kant Misra1

  • 1Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Insights

Hyperhomocysteinemia is a significant, treatable risk factor for cerebral venous sinus thrombosis (CVST), particularly in Indian populations. Many patients have low vitamin B12 or MTHFR mutations, highlighting key areas for intervention.

Area of Science:

  • Neurology
  • Thrombosis Research
  • Nutritional Biochemistry

Background:

  • Vegetarian diets can lead to vitamin B12 deficiency and hyperhomocysteinemia.
  • Hyperhomocysteinemia is linked to thrombotic conditions like cerebral venous sinus thrombosis (CVST).
  • Limited data exists on the clinico-radiological presentation and outcomes of hyperhomocysteinemic CVST patients.

Purpose of the Study:

  • To investigate the relationship between homocysteine (Hcy), vitamin B12, folic acid, and MTHFR mutations in CVST patients.
  • To compare the clinical and radiological severity and outcomes of CVST patients with and without hyperhomocysteinemia.

Main Methods:

  • Included 96 CVST patients with measured Hcy levels.
  • Assessed risk factors, neurological status, and MR imaging/venography findings.
  • Evaluated prothrombotic conditions: Hcy, vitamin B12, folic acid, and MTHFR 677C→T mutation; outcomes assessed at 3 months.

Main Results:

  • Hyperhomocysteinemia was present in 52.1% of patients; 32% had no other identified thrombotic cause.
  • Patients with hyperhomocysteinemia showed higher rates of vitamin B12 deficiency (70% vs. 13%) and MTHFR 677C→T mutation (47.5% vs. 9.1%).
  • Clinico-radiological severity and 3-month outcomes were similar between hyperhomocysteinemic and normohomocysteinemic groups.

Conclusions:

  • Hyperhomocysteinemia is a crucial, modifiable risk factor for CVST in Northern Indian patients.
  • Low vitamin B12 levels or MTHFR mutations were common in hyperhomocysteinemic CVST patients.
  • Early detection and management of hyperhomocysteinemia are vital for CVST prevention and treatment.
Abstract

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
89
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
85
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
82
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K